VC-backed Cortendo files for IPO
Cortendo AB, a Swedish biopharmaceutical company focused on orphan endocrine disorders, has filed for an IPO. The number of shares that will be sold as well as the stock's pricing terms have yet to be set. Cortendo will trade on the NASDAQ under the ticker symbol "SBBP." BofA Merrill Lynch and Stifel are serving as the lead underwriters. Cortendo's backers include Longwood Capital, TVM Capital, Granite Point Capital, RA Capital, New Enterprise Associates, Broadfin Capital and HealthCap.
31 August 2015•2 mins read
